Stockscreener 앱 받기
23.78
1.05%
0.2573
전일 마감가:
$23.52
열려 있는:
$23.32
하루 거래량:
1.27M
Relative Volume:
0.42
시가총액:
$5.85B
수익:
$426.45M
순이익/손실:
$197.67M
주가수익비율:
29.00
EPS:
0.82
순현금흐름:
$110.10M
1주 성능:
-3.03%
1개월 성능:
+31.97%
6개월 성능:
+26.22%
1년 성능:
+249.02%
1일 변동 폭
$23.30
$24.17
1주일 범위
$22.43
$24.48
52주 변동 폭
$6.72
$25.67
Adma Biologics Inc Stock (ADMA) Company Profile
명칭
Adma Biologics Inc
전화
(201) 478-5552
주소
C/O ADMA BIOLOGICS, INC., RAMSEY
ADMA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ADMA
Adma Biologics Inc
|
23.77 | 5.85B | 426.45M | 197.67M | 110.10M | 0.82 |
|
VRTX
Vertex Pharmaceuticals Inc
|
502.76 | 127.64B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
606.37 | 65.95B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ARGX
Argen X Se Adr
|
655.71 | 37.92B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
269.39 | 32.98B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
254.24 | 26.89B | 3.81B | -644.79M | -669.77M | -6.24 |
Adma Biologics Inc Stock (ADMA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2023-07-19 | 재개 | Raymond James | Strong Buy |
| 2022-10-13 | 개시 | Mizuho | Buy |
| 2021-11-11 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2021-11-09 | 개시 | Cantor Fitzgerald | Overweight |
| 2019-06-04 | 개시 | Jefferies | Buy |
| 2019-04-15 | 재확인 | H.C. Wainwright | Buy |
| 2019-02-07 | 재개 | H.C. Wainwright | Buy |
| 2017-12-11 | 재확인 | Maxim Group | Buy |
| 2017-11-14 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2017-01-23 | 업그레이드 | Maxim Group | Hold → Buy |
| 2016-08-01 | 다운그레이드 | Maxim Group | Buy → Hold |
| 2016-07-25 | 재확인 | Maxim Group | Buy |
| 2015-05-13 | 재확인 | Maxim Group | Buy |
| 2014-12-08 | 개시 | Oppenheimer | Outperform |
| 2014-12-01 | 재확인 | Maxim Group | Buy |
모두보기
Adma Biologics Inc 주식(ADMA)의 최신 뉴스
Take the Zacks Approach to Beat the Markets: ADMA Biologics, Limbach, Quest Diagnostics in Focus - TradingView
Should ADMA Biologics Stock Be in Your Portfolio Pre-Q1 Earnings? - MSN
Adma Biologics (ADMA) Increases Yet Falls Behind Market: What Investors Need to Know - Yahoo
Investors Heavily Search ADMA Biologics Inc (ADMA): Here is What You Need to Know - MSN
Bausch Health Q1 Earnings and Revenues Miss Estimates, Stock Down - The Globe and Mail
Has ADMA Biologics (ADMA) Outpaced Other Medical Stocks This Year? - Yahoo Finance
Recent Price Trend in Adma Biologics (ADMA) is Your Friend, Here's Why - Yahoo Finance
Why ADMA Biologics, Inc. (ADMA) Surged on Monday - MSN
The Zacks Analyst Blog Highlights ADMA, FirstCash, Stride, Life Time Group and National Fuel Gas - Yahoo Finance
These 5 Buy-Ranked Mid-Cap Stocks Are Flying High Year to Date - The Globe and Mail
ADMA Biologics to Report First Quarter 2025 Financial Results on May 7, 2025 - The Manila Times
ADMA Biologics Q1 2025 Earnings: Key Financial Updates Coming May 7 for Growing Biopharmaceutical Leader - Stock Titan
Adma Biologics (ADMA) Stock Slides as Market Rises: Facts to Know Before You Trade - MSN
ADMA Biologics (ADMA) Achieves Key FDA Approval for Production B - GuruFocus
ADMA Biologics (ADMA) Attracts Hedge Fund Attention Amid Takeover Speculation - GuruFocus
ADMA Biologics stock soars to all-time high of $24.02 By Investing.com - Investing.com South Africa
ADMA Biologics (ADMA) Gains FDA Approval for Yield Enhancement P - GuruFocus
Sector Update: Health Care Stocks Swing Between Small Gains, Losses - marketscreener.com
Noteworthy Monday Option Activity: ADMA, MAR, HUM - Nasdaq
Sector Update: Health Care - marketscreener.com
What's Going On With ADMA Stock Monday?ADMA Biologics (NASDAQ:ADMA) - Benzinga
ADMA Biologics stock soars to all-time high of $24.02 - Investing.com
Cemex Posts Q1 Results, Joins Plug Power, Sabre And Other Big Stocks Moving Higher On Monday - Benzinga
Adma Biologics Announces U.S. Fda Approval of Innovative Production Yield Enhancement Process - marketscreener.com
FDA Approves ADMA Biologics' Innovative Production Yield Enhancement Process - Nasdaq
ADMA Biologics Receives FDA Approval for Innovative Yield Enhancement Process, Paving the Way for Increased Production Capacity and Revenue Growth - Nasdaq
ADMA Biologics Announces U.S. FDA Approval of Innovative Production Yield Enhancement Process - Bluefield Daily Telegraph
ADMA Biologics Achieves Industry First: FDA Green Lights Revolutionary 20% Plasma Yield Enhancement - Stock Titan
Press Release Distribution & PR Platform - ACCESS Newswire
20 Takeover Rumors Hedge Funds Are Buying - Insider Monkey
ADMA Biologics, Inc. (ADMA): Among Takeover Rumors Hedge Funds Are Buying - MSN
10 Best Multibagger Stocks to Buy According to Billionaires - Insider Monkey
Is ADMA Biologics, Inc. (ADMA) the Best Multibagger Stock to Buy According to Billionaires? - Insider Monkey
Adma Biologics (ADMA) Gains But Lags Market: What You Should Know - Yahoo
Why ADMA Biologics Inc. (ADMA) Performed Worst On Monday? - Insider Monkey
Adma Biologics Inc (ADMA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Adma Biologics Inc 주식 (ADMA) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Grossman Adam S | President and CEO |
Apr 15 '25 |
Sale |
21.46 |
21,000 |
450,660 |
2,055,850 |
| Grossman Adam S | President and CEO |
Mar 19 '25 |
Option Exercise |
5.40 |
15,000 |
81,000 |
2,082,850 |
| Grossman Adam S | President and CEO |
Mar 19 '25 |
Sale |
18.92 |
21,000 |
397,320 |
2,061,850 |
0.08%
0.47%
자본화:
|
볼륨(24시간):